Skip to content

Virtual Asthma Clinic for Children.

Can the introduction of a virtual asthma clinic improve the number of asthma free days in children with asthma while reducing visits to the outpatient clinic by 50%?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27750
Enrollment
210
Registered
2011-01-11
Start date
2011-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Children, Digital Care, Virtual Clinic, Managment, Self-management

Interventions

Randomized allocation tot usual care (outpatient clinic vist every 4 months) or access to virtual asthma clinic (outpatient clinic visits every 8 months). The virtual asthma clinic consist of a websi
2. A forum on which questions can be asked and tips can be shared
3. A shielded privat module on which the personal treatment (maintenance and attack treatment) can be consulted and on which de patient or parent freely, easily and always can communicate with the doc

Sponsors

UMC St Radboud
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children with doctor’s diagnosed asthma (based on clinical symptoms, bronchodilator response of FEV1 of > 9% of predicted and/or airway hyperresponsiveness and/or signs of chronic airways inflammation (elevated FENO)); 2. At least one allergy for airborne allergens proven by positive skin prick tests and/or blood tests; 3. Between 6 and 18 years of age; 4. Have a computer with internet connection at home.

Exclusion criteria

Exclusion criteria: 1. A history of admission to the intensive care unit for asthma in the preceding 5 years; 2. Difficult to treat asthma (defined as uncontrolled or poorly controlled asthma in spite of maintenance treatment with inhaled corticosteroids with at least 800 micrograms budesonide or equivalent per day, long acting bronchodilators and/or Montelukast®, and/or oral corticosteroids); 3. Use of Omalizumab® for severe allergic asthma; 4. Other chronic diseases; 5. Inability of the parents or older children to understand or read Dutch.

Design outcomes

Primary

MeasureTime frame
The number of asthma free days during the last 4 weeks of the study.

Secondary

MeasureTime frame
1. Forced expiratory volume in one second (FEV1); 2. Exhaled fraction of Nitric Oxide (FENO); 3. Results of the Asthma control test (ACT-questionnaire) at 0, 8 and 16 months; 4. Hospital admissions; 5. Unscheduled health visits; 6. Exacerbations; 7. Additional contacts or visits with the asthma management team or general physician; 8. Courses of prednisolone.

Contacts

Public ContactJ. Roukema

Postbus 9101

j.roukema@cukz.umcn.nl+31 (0)24 3613670

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)